Hikma to present at the 31st Annual J.P. Morgan Healthcare Conference

London, 3 January 2013 - Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (“Hikma”), the fast growing multinational pharmaceutical group, today announces that Mazen Darwazah, Executive Vice-Chairman and CEO of MENA, will present at the 31st Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013 in San Francisco.

Press Release Corporate 3 January 2013

The presentation is scheduled to begin at 14.30 Pacific Time, 17.30 Eastern Time and 22.30 GMT.  The slides accompanying the presentation will be available on the Hikma website at www.hikma.com.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.